Effect of 24-hour whole-blood storage on plasma clotting factors

Transfusion

Volumn 39, Issue 5, 1999, Pages 488-491

  O'Neill, E Mary ^a   Rowley, J ^b   Hansson Wicher, M ^b   McCarter, S ^b   Ragno, G ^b   Valeri, C R ^b  

^a AMERICAN RED CROSS BLOOD SERVICES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; FIBRINOGEN; FRESH FROZEN PLASMA; PRESERVATIVE; PROTEIN C; PROTEIN S;

ANTICOAGULATION; ARTICLE; BLOOD BANK; BLOOD DONOR; BLOOD STORAGE; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; NORMAL HUMAN; PHLEBOTOMY; PLASMA HALF LIFE; TEMPERATURE;

ANALYSIS OF VARIANCE; BLOOD COAGULATION FACTORS; BLOOD COMPONENT REMOVAL; BLOOD DONORS; BLOOD PRESERVATION; ERYTHROCYTES; HUMANS; PLASMA; TIME FACTORS;

EID: 0032959271     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1999.39050488.x     Document Type: Article

References (19)

1. Menitove JE, ed. Standards for blood banks and transfusion services. 18th ed. Bethesda: American Association of Blood Banks, 1997:15.
2. NIH Consensus Development Panel. Fresh-frozen plasma: indications and risks. JAMA 1985;253:551-3.
3. Vengelen-Tyler V, ed. Technical manual. 12th ed. Bethesda: American Association of Blood Banks, 1996:136-7.
4. Briggs R, Rizza C. Human blood coagulation, haemostasis, and thrombosis. 3rd ed. Oxford: Blackwell, 1984.
5. Comp PC, Nixon R, Esmon CT. Determinations of functional levels of protein C, an antithromobotic protein, using thrombin/thrombomodulin complex. Blood 1984;63:16-21.
6. Rosenberg RD. Actions and interactions of antithrombin and heparin. N. Engl J Med 1975;292:146-51.
7. Smith J, Ness PM, Moroff G, Luban NLC. Retention of coagulation factors in plasma frozen within 24 hours after phlebotomy (abstract). Transfusion 1993;33(Suppl):S33.
8. Hughes C, Thomas KB, Schiff P, et al. Effect of delayed blood processing on the yield of factor VIII in cryoprecipitate and factor VIII concentrate. Transfusion 1988;28:566-70.
9. Pepper MD, Learoyd PA, Rajah SM. Plasma factor VIII, variables affecting stability under standard blood bank conditions and correlation with recovery in concentrates. Transfusion 1978;18:756-60.
10. Moroff G, Holme S, Heaton WAL, et al. Effect of an 8 hour holding period on in vivo and in vitro properties of red cells and factor VIII content of plasma after collection in a red cell additive system, Transfusion 1990;30:828-32.
11. Nilsson L, Hedner U, Nilsson M, Robertson B. Shelf-life of bank blood and stored plasma with special reference to coagulation factors. Transfusion 1983;23:377-81.
12. Milam JD, Buzzurro CJ, Austin SF, Stansberry SW. Stability of factors V and VIII in thawed frozen plasma units. Transfusion 1980;20:546-8.
13. Kakaiya RM, Morse EE, Panek S. Labile coagulation factors in thawed fresh frozen plasma prepared by two methods. Vox Sang 1984;46:44-6.
14. Sohmer PR, Bolin RB, Scott RL, Smith DJ. Effect of delayed refrigeration on plasma factors in whole blood collected in CPDA-2. Transfusion 1982;22:488-90.
15. Inkster M, Sherman LA, Ahmed P, et al. Preservation of antithrombin III activity in stored whole blood. Transfusion 1984;24:57-9.
16. Circular of information for the use of human blood and blood components. Bethesda: American Association of Blood Banks, 1997:20.
17. Hellstern P, Sachse H, Schwinn H, et al. Manufacture and in vitro characterization of solvenr/detergent-treated human plasma. Vox Sang 1992;63:178-85.
18. Horowitz B, Bonomo R, Prince AM, et al. Solvent/detergent-treated plasma: a virus-inactivated substitute for fresh frozen plasma. Blood 1992; 79:826-31.
19. Klein HG, Dodd RY, Dzik WH, et al. Current status of solvent/detergent-treated frozen plasma. Transfusion 1998;38:102-7.